These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease. Inomata H; Rao NA Am J Ophthalmol; 2001 May; 131(5):607-14. PubMed ID: 11336935 [TBL] [Abstract][Full Text] [Related]
7. Unusual Case of Vogt-Koyanagi-Harada Syndrome Presenting as Non-specific Headache. A V P; Kumar J S A; K N N; Rao S; Shetty S J Clin Diagn Res; 2014 Apr; 8(4):VD06-VD07. PubMed ID: 24959501 [TBL] [Abstract][Full Text] [Related]
8. [Progresses and existed problems on the diagnosis and treatment of Vogt-Koyanagi-Harada disease]. Zheng YZ Zhonghua Yan Ke Za Zhi; 2012 Jun; 48(6):572-6. PubMed ID: 22943816 [TBL] [Abstract][Full Text] [Related]
9. Vogt-koyanagi-harada syndrome. Fang W; Yang P Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484 [TBL] [Abstract][Full Text] [Related]
10. Headache as an initial manifestation of Vogt-Koyanagi-Harada disease. Khairallah AS Saudi J Ophthalmol; 2014 Jul; 28(3):239-42. PubMed ID: 25278805 [TBL] [Abstract][Full Text] [Related]
12. Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality. Herbort CP; Abu El Asrar AM; Yamamoto JH; Pavésio CE; Gupta V; Khairallah M; Tugal-Tutkun I; Soheilian M; Takeuchi M; Papadia M Int Ophthalmol; 2017 Dec; 37(6):1383-1395. PubMed ID: 27844182 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and classification of Vogt-Koyanagi-Harada disease. Sakata VM; da Silva FT; Hirata CE; de Carvalho JF; Yamamoto JH Autoimmun Rev; 2014; 13(4-5):550-5. PubMed ID: 24440284 [TBL] [Abstract][Full Text] [Related]
14. Early resolution of subretinal fluid without high-dose corticosteroids in a pregnant patient with Vogt-Koyanagi-Harada disease: a case report. Sugita K; Mizumoto K; Kato N; Zako M J Ophthalmic Inflamm Infect; 2015; 5():20. PubMed ID: 26140057 [TBL] [Abstract][Full Text] [Related]
16. New insights into Vogt-Koyanagi-Harada disease. Damico FM; Bezerra FT; Silva GC; Gasparin F; Yamamoto JH Arq Bras Oftalmol; 2009; 72(3):413-20. PubMed ID: 19668980 [TBL] [Abstract][Full Text] [Related]
17. New Perspectives on the Immunopathogenesis and Treatment of Uveitis Associated With Vogt-Koyanagi-Harada Disease. Abu El-Asrar AM; Van Damme J; Struyf S; Opdenakker G Front Med (Lausanne); 2021; 8():705796. PubMed ID: 34869409 [TBL] [Abstract][Full Text] [Related]
18. Annular choroidal detachment in a patient with Vogt-Koyanagi-Harada disease. Yamamoto N; Naito K Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):355-8. PubMed ID: 14963715 [TBL] [Abstract][Full Text] [Related]
19. Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. Papasavvas I; Herbort CP J Ophthalmic Inflamm Infect; 2021 Jul; 11(1):21. PubMed ID: 34224024 [TBL] [Abstract][Full Text] [Related]
20. [Vogt-Koyanagi-Harada syndrome. Eight cases]. Alaoui FZ; Benamour S; El Kabli H; Amraoui A Rev Med Interne; 2007 Apr; 28(4):250-4. PubMed ID: 17350144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]